Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor

被引:14
|
作者
Bertini, Simone [1 ]
Chicca, Andrea [2 ]
Gado, Francesca [1 ]
Arena, Chiara [1 ]
Nieri, Daniela [2 ]
Digiacomo, Maria [1 ]
Saccomanni, Giuseppe [1 ]
Zhao, Pingwei [3 ]
Abood, Mary E. [3 ]
Macchia, Marco [1 ]
Gertsch, Jurg [2 ]
Manera, Clementina [1 ]
机构
[1] Univ Pisa, Dept Pharm, I-56126 Pisa, Italy
[2] Univ Bern, NCCR TransCure, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland
[3] Temple Univ, Lewis Katz Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA
关键词
Allosteric modulator; CB1; receptor; Endocannabinoid system; MAPK/ERK signaling pathway; Serum response element; ENDOCANNABINOID SYSTEM; HUMAN HEALTH; PHARMACOLOGY; STRATEGIES; AGONISTS; PAIN;
D O I
10.1016/j.bmc.2017.10.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this work, we explored the molecular framework of the known CB1R allosteric modulator PSNCBAM-1 with the aim to generate new bioactive analogs and to deepen the structure-activity relationships of this type of compounds. In particular, the introduction of a NH group between the pyridine ring and the phenyl nucleus generated the amino-phenyl-urea derivative SN15b that behaved as a positive allosteric modulator (PAM), increasing the CB1R binding affinity of the orthosteric ligand CP55,940. The functional activity was evaluated using serum response element (SRE) assay, which assesses the CB1R-dependent activation of the MAPK/ERK signaling pathway. SN15b and the biphenyl-urea analog SC4a significantly inhibited the response produced by CP55,940 in the low mu M range, thus behaving as negative allosteric modulators (NAMs). The new derivatives presented here provide further insights about the modulation of CB1R binding and functional activity by allosteric ligands. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6427 / 6434
页数:8
相关论文
共 50 条
  • [21] Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1
    Xin Yang
    Xuehui Wang
    Zheng Xu
    Chao Wu
    Yangli Zhou
    Yifei Wang
    Guifeng Lin
    Kan Li
    Ming Wu
    Anjie Xia
    Jingming Liu
    Lin Cheng
    Jun Zou
    Wei Yan
    Zhenhua Shao
    Shengyong Yang
    Nature Chemical Biology, 2022, 18 : 831 - 840
  • [22] Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1
    Yang, Xin
    Wang, Xuehui
    Xu, Zheng
    Wu, Chao
    Zhou, Yangli
    Wang, Yifei
    Lin, Guifeng
    Li, Kan
    Wu, Ming
    Xia, Anjie
    Liu, Jingming
    Cheng, Lin
    Zou, Jun
    Yan, Wei
    Shao, Zhenhua
    Yang, Shengyong
    NATURE CHEMICAL BIOLOGY, 2022, 18 (08) : 831 - +
  • [23] Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
    Laprairie, R. B.
    Bagher, A. M.
    Kelly, M. E. M.
    Denovan-Wright, E. M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (20) : 4790 - 4805
  • [24] Identification of an allosteric binding site at the cannabinoid CB1 receptor
    Barber, Teresa S.
    Hurst, Dow P.
    Reggio, Patricia H.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [25] Tuning the endocannabinoid system:: allosteric modulators of the CB1 receptor
    Ross, R. A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (05) : 565 - 566
  • [26] Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution
    Nguyen, Thuy
    German, Nadezhda
    Decker, Ann M.
    Langston, Tiffany L.
    Gamage, Thomas F.
    Farquhar, Charlotte E.
    Li, Jun-Xu
    Wiley, Jenny L.
    Thomas, Brian F.
    Zhang, Yanan
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (17) : 7410 - 7424
  • [27] Could positive allosteric modulators of the cannabinoid CB1 receptor be efficacious and safe for the treatment of chronic pain?
    Green, Hayley M.
    Glass, Michelle
    CURRENT OPINION IN PHARMACOLOGY, 2024, 79
  • [28] Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor
    Khajehali, Elham
    Malone, Daniel T.
    Glass, Michelle
    Sexton, Patrick M.
    Christopoulos, Arthur
    Leach, Katie
    MOLECULAR PHARMACOLOGY, 2015, 88 (02) : 368 - 379
  • [29] Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor
    Thuy Nguyen
    Li, Jun-Xu
    Thomas, Brian F.
    Wiley, Jenny L.
    Kenakin, Terry P.
    Zhang, Yanan
    MEDICINAL RESEARCH REVIEWS, 2017, 37 (03) : 441 - 474
  • [30] Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery
    Gado, Francesca
    Meini, Serena
    Bertini, Simone
    Digiacomo, Maria
    Macchia, Marco
    Manera, Clementina
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (15) : 2019 - 2037